InvestorsHub Logo
Followers 41
Posts 3508
Boards Moderated 2
Alias Born 09/20/2007

Re: None

Saturday, 12/15/2018 4:19:03 PM

Saturday, December 15, 2018 4:19:03 PM

Post# of 34013
News from last week... surprised nobody posted it.

PROTEXT PHARMA ANNOUNCES EXPANSION OF CANNABIS LICENSE AGREEMENT WITH MAJORITY SHAREHOLDER PLANDIA BIOTECHNOLOGY, INC.

Florida, USA -- December 7, 2018 -- InvestorsHub NewsWire -- Protext Pharma, Inc. (PINKSHEETS: TXTM) ("Protext" or "the Company"), a biotech company engaged in the development of botanical medicines that are formulated with highly-bioavailable plant extracts, is pleased to announce it has executed positive amendments to the agreement with its majority stakeholder, Plandai Biotechnology, Inc. (PLPL), to clarify, modify and expand the license agreement held by the Company’s wholly-owned subsidiary, Cannabis Bioscience, Inc. According to the Company, these changes enable Protext to quickly ramp up building a platform to develop cannabis products in the US which would include developing both cannabis and hemp-based extracts for nutraceutical applications and have cannabis products ready for market inside of six months through a joint venture.

[...continues for several more paragraphs...]

https://ih.advfn.com/stock-market/USOTC/protext-mobility-inc-TXTM/stock-news/78845431/protext-pharma-announces-expansion-of-cannabis-lic

Watch for opportunities with those you trust.